2016 
https://annual.inven2.com/2016/en/a-word-from-the-ceo/
https://annual.inven2.com/2016/en/featured_item/vaccibody-2/ 
https://annual.inven2.com/2016/en/featured_item/ultimovacs-2/
https://annual.inven2.com/2016/en/featured_item/prosa-security-2/
https://annual.inven2.com/2016/en/featured_item/nordic-nanovector-2/
https://annual.inven2.com/2016/en/featured_item/lars-wik-2/
https://annual.inven2.com/2016/en/featured_item/epiguard-2/
https://annual.inven2.com/2016/en/featured_item/elliptic-labs-2/
https://annual.inven2.com/2016/en/featured_item/betanien-hospital-2/
https://annual.inven2.com/2016/en/industrial-collaborations/
https://annual.inven2.com/2016/en/pre-seed-capital/
https://annual.inven2.com/2016/en/student-innovation/

2017
https://annual.inven2.com/2017/en/a-word-from-the-ceo/
https://annual.inven2.com/2017/en/featured_item/coorstek-membrane-sciences-as/
https://annual.inven2.com/2017/en/featured_item/fate-therapeutics-ous-2/
https://annual.inven2.com/2017/en/featured_item/kite-pharma-ous-2/
https://annual.inven2.com/2017/en/featured_item/the-cancer-registry-of-norway-msd/
https://annual.inven2.com/2017/en/featured_item/winner-of-ideprisen-2017-ous/
https://annual.inven2.com/2017/en/featured_item/novartis-ous/
https://annual.inven2.com/2017/en/featured_item/ultimovacs-as/
https://annual.inven2.com/2017/en/featured_item/offpad-as-2/
https://annual.inven2.com/2017/en/featured_item/oncoinvent-as/
https://annual.inven2.com/2017/en/clinical-trials/
https://annual.inven2.com/2017/en/featured_item/catapult-2/
https://annual.inven2.com/2017/en/ecosystem/
https://annual.inven2.com/2017/en/featured_item/winner-of-ideprisen-2017-ous/
https://annual.inven2.com/2017/en/successful-matchmaking-at-cutting-edge/
https://annual.inven2.com/2017/en/student-innovation
https://annual.inven2.com/2017/en/featured_item/probnp/
https://annual.inven2.com/2017/en/featured_item/quest-5-hmc-dna-elisa-kit-2/
https://annual.inven2.com/2017/en/featured_item/medical-thermo-band-2/
https://annual.inven2.com/2017/en/featured_item/promon-shield-2/
https://annual.inven2.com/2017/en/featured_item/inner-beauty-2/
https://annual.inven2.com/2017/en/featured_item/epishuttle-2/
https://annual.inven2.com/2017/en/reorganisation-and-major-focus-on-digitalisation-and-e-health/

2018
https://annual.inven2.com/2018/en/innovation-how-do-you-take-your-research-to-market/
https://annual.inven2.com/2018/en/featured_item/kirurgi-med-virtuelt-rontgensyn/
https://annual.inven2.com/2018/en/featured_item/weather-forecast-for-outer-space-and-a-potential-new-way-of-flying/
https://annual.inven2.com/2018/en/featured_item/developing-a-unique-cardiac-treatment/
https://annual.inven2.com/2018/en/featured_item/inven2pitch-2/
https://annual.inven2.com/2018/en/featured_item/the-ideprisen-2018/
https://annual.inven2.com/2018/en/featured_item/legal-focus-group/
https://annual.inven2.com/2018/en/featured_item/student-innovation/
https://annual.inven2.com/2018/en/featured_item/spark-norway-2/
https://annual.inven2.com/2018/en/featured_item/nordic-life-science-days-2/
https://annual.inven2.com/2018/en/featured_item/bone-marrow-cancer/
https://annual.inven2.com/2018/en/featured_item/melanoma-cancer/
https://annual.inven2.com/2018/en/featured_item/child-cancer/
https://annual.inven2.com/2018/en/clinical-trials/
https://annual.inven2.com/2018/en/a-word-from-the-ceo/
https://annual.inven2.com/2018/en/featured_item/vaccibody-2/
https://annual.inven2.com/2018/en/featured_item/meshcrafts-3/
https://annual.inven2.com/2018/en/featured_item/catalysts-2/
https://annual.inven2.com/2018/en/featured_item/probnp/
https://annual.inven2.com/2018/en/featured_item/quest-5-hmc-dna-elisa-kit-2/
https://annual.inven2.com/2018/en/featured_item/medical-thermo-band-2/
https://annual.inven2.com/2018/en/featured_item/promon-shield-2/
https://annual.inven2.com/2018/en/featured_item/inner-beauty-2/
https://annual.inven2.com/2018/en/featured_item/epishuttle-2/
https://annual.inven2.com/2018/en/ecosystem/

2019
https://annual.inven2.com/2019/en/innovation-how-do-you-take-your-research-to-market/
https://annual.inven2.com/2019/en/innovation-how-do-you-take-your-research-to-market/
https://annual.inven2.com/2019/en/featured_item/radiopharmaceuticals-2/
https://annual.inven2.com/2019/en/featured_item/immunotherapy/
https://annual.inven2.com/2019/en/featured_item/diagnostic_imaging/
https://annual.inven2.com/2019/en/featured_item/student-innovation/
https://annual.inven2.com/2019/en/featured_item/inven2pitch-2/
https://annual.inven2.com/2019/en/featured_item/the-ideprisen-2019/
https://annual.inven2.com/2019/en/featured_item/skin-diseases/
https://annual.inven2.com/2019/en/featured_item/rare_disease/
https://annual.inven2.com/2019/en/featured_item/gastroenterology/
https://annual.inven2.com/2019/en/clinical-trials/
https://annual.inven2.com/2019/en/a-word-from-the-ceo/
https://annual.inven2.com/2019/en/useful-and-important-matcmaking-at-cutting-edge/
https://annual.inven2.com/2019/en/featured_item/offpad-3/
https://annual.inven2.com/2019/en/featured_item/ultimovacs-2/
https://annual.inven2.com/2019/en/featured_item/serca-2/
https://annual.inven2.com/2019/en/featured_item/medical-thermo-band-2/
https://annual.inven2.com/2019/en/featured_item/promon-shield-2/
https://annual.inven2.com/2019/en/featured_item/inner-beauty-2/
https://annual.inven2.com/2019/en/featured_item/epishuttle-2/
https://annual.inven2.com/2019/en/featured_item/probnp/
https://annual.inven2.com/2019/en/featured_item/quest-5-hmc-dna-elisa-kit-2/
https://annual.inven2.com/2019/en/ecosystem/

2020
https://annual.inven2.com/2020/en/a-word-from-the-ceo/
https://annual.inven2.com/2020/en/innovation-how-do-you-take-your-research-to-market/
https://annual.inven2.com/2020/en/innovation-how-do-you-take-your-research-to-market/
https://annual.inven2.com/2020/en/featured_item/digital-assistance-for-life-skills/
https://annual.inven2.com/2020/en/featured_item/unique-biological-super-taxi/
https://annual.inven2.com/2020/en/featured_item/domore-2/
https://annual.inven2.com/2020/en/clinical-trials/
https://annual.inven2.com/2020/en/featured_item/attracting-virtual-clinical-trials-to-norway/
https://annual.inven2.com/2020/en/featured_item/analysing-samples-from-paediatric-oncology-patients-throughout-europe/
https://annual.inven2.com/2020/en/featured_item/clinical-studies-important-for-norwegian-companies/
https://annual.inven2.com/2020/en/clinical-trials/
https://annual.inven2.com/2020/en/featured_item/inven2-10-years/
https://annual.inven2.com/2020/en/featured_item/fridtjof-heyerdahl-2/
https://annual.inven2.com/2020/en/featured_item/heidi-glosli/
https://annual.inven2.com/2020/en/featured_item/fredrik-schjesvold/
https://annual.inven2.com/2020/en/featured_item/christian-hall-2/
https://annual.inven2.com/2020/en/featured_item/else-marit-inderberg-2/
https://annual.inven2.com/2020/en/featured_item/vaccibody-2/
https://annual.inven2.com/2020/en/featured_item/zelluna/
https://annual.inven2.com/2020/en/featured_item/epiguard-2/
https://annual.inven2.com/2020/en/featured_item/probnp/
https://annual.inven2.com/2020/en/featured_item/quest-5-hmc-dna-elisa-kit-2/
https://annual.inven2.com/2020/en/featured_item/medical-thermo-band-2/
https://annual.inven2.com/2020/en/featured_item/promon-shield-2/
https://annual.inven2.com/2020/en/featured_item/inner-beauty-2/
https://annual.inven2.com/2020/en/featured_item/epishuttle-2/
https://annual.inven2.com/2020/en/ecosystem/

2021
https://annual.inven2.com/2021/en/a-word-from-the-ceo/
https://annual.inven2.com/2021/en/innovation-how-do-you-take-your-research-to-market/
https://annual.inven2.com/2021/en/innovation-how-do-you-take-your-research-to-market/
https://annual.inven2.com/2021/en/featured_item/digital-assistance-for-life-skills/
https://annual.inven2.com/2021/en/featured_item/unique-biological-super-taxi/
https://annual.inven2.com/2021/en/featured_item/domore-2/
https://annual.inven2.com/2021/en/clinical-trials/
https://annual.inven2.com/2021/en/featured_item/attracting-virtual-clinical-trials-to-norway/
https://annual.inven2.com/2021/en/featured_item/analysing-samples-from-paediatric-oncology-patients-throughout-europe/
https://annual.inven2.com/2021/en/featured_item/clinical-studies-important-for-norwegian-companies/
https://annual.inven2.com/2021/en/clinical-trials/
https://annual.inven2.com/2021/en/featured_item/vaccibody-2/
https://annual.inven2.com/2021/en/featured_item/zelluna/
https://annual.inven2.com/2021/en/featured_item/epiguard-2/
https://annual.inven2.com/2021/en/featured_item/probnp/
https://annual.inven2.com/2021/en/featured_item/quest-5-hmc-dna-elisa-kit-2/
https://annual.inven2.com/2021/en/featured_item/medical-thermo-band-2/
https://annual.inven2.com/2021/en/featured_item/promon-shield-2/
https://annual.inven2.com/2021/en/featured_item/inner-beauty-2/
https://annual.inven2.com/2021/en/featured_item/epishuttle-2/
https://annual.inven2.com/2021/en/ecosystem/

2022
https://annual.inven2.com/2022/en/featured_item/attracting-virtual-clinical-trials-to-norway/
https://annual.inven2.com/2022/en/featured_item/analysing-samples-from-paediatric-oncology-patients-throughout-europe/
https://annual.inven2.com/2022/en/featured_item/clinical-studies-important-for-norwegian-companies/
https://annual.inven2.com/2022/en/featured_item/vaccibody-2/
https://annual.inven2.com/2022/en/featured_item/zelluna/
https://annual.inven2.com/2022/en/featured_item/epiguard-2/
https://annual.inven2.com/2022/en/featured_item/probnp/
https://annual.inven2.com/2022/en/featured_item/medical-thermo-band-2/
https://annual.inven2.com/2022/en/featured_item/promon-shield-2/
https://annual.inven2.com/2022/en/featured_item/inner-beauty-2/
https://annual.inven2.com/2022/en/featured_item/epishuttle-2/
https://annual.inven2.com/2022/en/featured_item/multi-needle-langmuir-probe-m-nlp/